James Investment Research’s Express Scripts Holding Company ESRX Stock Holding History

James Investment Research’s Portfolio ESRX Stock Details ESRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-25,461	Closed	-$2.42M	–	920
2018 Q3	$2.42M	Sell	25,461 -6,010	-19%	-$512K	0.1%	204
2018 Q2	$2.43M	Buy	31,471 +3,603	+13%	+$270K	0.09%	231
2018 Q1	$1.93M	Sell	27,868 -2,373	-8%	-$181K	0.07%	334
2017 Q4	$2.26M	Buy	30,241 +656	+2%	+$42K	0.08%	235
2017 Q3	$1.87M	Buy	29,585 +10,950	+59%	+$681K	0.06%	279
2017 Q2	$1.19M	Buy	+18,635	New	+$1.17M	0.04%	371

Other funds holding ESRX

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $5.38B AUM 27.31% 1-Year Est. Return

BSPF

British Steel Pension Fund London, United Kingdom $410M AUM 11.96% 1-Year Est. Return

MYAM

Meiji Yasuda Asset Management Tokyo, Japan $2.22B AUM 32.92% 1-Year Est. Return

AWM

Alterna Wealth Management Houston, Texas $174M AUM 15.45% 1-Year Est. Return

Wealthquest Cincinnati, Ohio $1.59B AUM 18.1% 1-Year Est. Return

ACA

Atlas Capital Advisors Jackson, Wyoming $914M AUM

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

SBL

Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return

James Investment Research's ESRX Position: Q4 2018 in Review

James Investment Research sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 25,461 shares — an estimated $2.42M sold.

James Investment Research first reported a position in ESRX in Q2 2017 and held it in 6 quarters. The position peaked at $2.43M in Q2 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

James Investment Research reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
James Investment Research sold 25,461 Express Scripts Holding Company shares in Q4 2018, an estimated $2.42M.
James Investment Research first reported a position in Express Scripts Holding Company in Q2 2017 and held it in 6 quarters.
James Investment Research's Express Scripts Holding Company position peaked at $2.43M in Q2 2018.
16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on James Investment Research's 13F filing for Q4 2018, filed 22 Jan 2019.